Prev Arrow Stocks

Cronos Group Inc. ($CRON) Stock Forecast: Up 2.3% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Cronos Group Inc.?

CRON (Cronos Group Inc.) is a Canadian cannabis company specializing in medical and recreational marijuana products. The cannabis market has shown volatility influenced by regulatory changes and public opinion.

Why is Cronos Group Inc. going up?

CRON stock is up 2.3% on Sep 29, 2025 17:55

  • President Trump's support for CBD on Truth Social led to a surge in cannabis stock prices, including CRON.
  • Despite the initial increase, CRON experienced a drop in market cap erasing the gains following Trump's post.
  • There are concerns in the community regarding the demand for CRON after the market rally, indicating a possible shift in sentiment.
  • The fluctuating movements in CRON following Trump's post highlight the unpredictable nature of cannabis stocks in response to political and regulatory developments.

CRON Price Chart

CRON Technical Analysis

CRON News

Trump Lights Up Cannabis Stocks With Pro-CBD Post - Tilray Brands ( NASDAQ:TLRY )

President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in federal drug policy. TLRY stock is on fire. See the real-time price action here.

https://www.benzinga.com/trading-ideas/movers/25/09/47918347/president-trump-lights-up-cannabis-stocks-with-pro-cbd-truth-social-post

0 News Article Image Trump Lights Up Cannabis Stocks With Pro-CBD Post - Tilray Brands  ( NASDAQ:TLRY )

Crypto.com's Cronos erases Trump pump gains, community questions demand

Since the peak of the Trump news-driven rally, Cronos has lost more than $6 billion, or nearly 50% of its market cap.

https://cointelegraph.com/news/cro-erases-trump-pump-gains-community-questions-demand

1 Missing News Article Image Crypto.com's Cronos erases Trump pump gains, community questions demand

Cronos Group Inc. Price History

06.10.2024 - CRON Stock was down 7.3%

  • CRON experienced a bearish movement despite the overall bullish trend in the cannabis sector.
  • The surge in other cannabis stocks like Australis Capital (AUSAF) and CordovaCann (LVRLF) might have diverted investor attention away from CRON.
  • It's possible that CRON faced specific challenges such as regulatory hurdles or disappointing earnings reports, leading to the bearish market movement.
  • Investors may have rotated their investments towards more promising opportunities within the cannabis industry, causing CRON to underperform compared to its peers.

31.09.2024 - CRON Stock was down 5.6%

  • CRON stock experienced a bearish movement possibly due to profit-taking after recent gains in other cannabis stocks like Australis Capital and Blueberries Medical.
  • The upcoming third-quarter earnings conference call may have raised concerns or uncertainty among investors, leading to a sell-off in CRON shares.
  • The positive performance of other cannabis stocks could have shifted investor focus away from CRON, causing a decline in its stock price.
  • Overall, the bearish movement in CRON today could be a combination of profit-taking in the cannabis sector and anticipation surrounding the upcoming earnings call.

14.10.2024 - CRON Stock was down 6.1%

  • The CEO of Cronos Group, Mike Gorenstein, expressed optimism about Trump's stance on cannabis reform.
  • Despite the positive outlook, Gorenstein warned against expecting rapid changes in the industry.
  • The market might have reacted negatively to the cautionary tone regarding the pace of reform, leading to the bearish movement in CRON stock.

08.04.2025 - CRON Stock was up 7.1%

  • The bullish movement in CRON today can be attributed to the launch of the Cronos token ETP by 21Shares in Europe and the US, providing investors with more exposure to the emerging web3 infrastructure.
  • The increased accessibility to Cronos blockchain through regulated investment products has likely generated excitement among investors, leading to a surge in demand for CRON shares.
  • This news highlights the growing interest in alternative assets like cryptocurrencies and blockchain technology, driving up the value of companies like Cronos Group that are involved in these innovative sectors.

08.04.2025 - CRON Stock was up 5.9%

  • Cronos Group (CRON) experienced a strong bullish movement today.
  • The launch of an exchange traded product (ETP) for Crypto.com's Cronos token in Europe and the US has likely increased investor interest and confidence in Cronos Group.
  • Cronos Group's positive net income and margin growth, as well as consistent REIT performance from IIPR, have contributed to the bullish market movement.
  • The market split in the cannabis industry, with some companies facing revenue declines while others like Cronos Group are thriving, may have also influenced investor sentiment towards CRON.

07.07.2025 - CRON Stock was up 12.4%

  • CRON stock had a strong bullish movement today.
  • The positive Q2 2025 results showed an increase in net revenue, potentially influencing the stock's rise.
  • Investors may be responding to the company's financial performance, leading to the stock price increase.
  • The overall positive outlook for the cannabis industry could also be impacting CRON's bullish movement.

12.10.2024 - CRON Stock was up 15.9%

  • The bullish movement in CRON today can be attributed to Google Cloud becoming the main validator on Cronos blockchain.
  • This partnership with Google Cloud is seen as a significant step towards enhancing Cronos' blockchain network's decentralization and security, which has likely boosted investor confidence in the company's future prospects.
  • The collaboration with reputable validators like Crypto.com and Blockdaemon further adds credibility to Cronos' blockchain infrastructure, potentially attracting more investors to the stock.
  • Overall, this positive development in the blockchain space for Cronos Group has contributed to the bullish movement in the stock today, reflecting optimism about the company's technological advancements and strategic partnerships.

29.08.2025 - CRON Stock was up 3.7%

  • CRON experienced a strong bullish movement despite recent losses in market cap, showcasing resilience in the face of market challenges.
  • The surge in CRON's stock price could be attributed to positive earnings reports or potential partnerships that have sparked investor optimism.
  • Despite the recent setbacks and market fluctuations, CRON's bullish movement indicates that investors still see long-term potential in the company's growth prospects.
  • The community's questioning of demand for Cronos products may have been overshadowed by positive developments within the company, leading to the bullish market movement.

29.08.2025 - CRON Stock was up 2.3%

  • President Trump's support for CBD on Truth Social led to a surge in cannabis stock prices, including CRON.
  • Despite the initial increase, CRON experienced a drop in market cap erasing the gains following Trump's post.
  • There are concerns in the community regarding the demand for CRON after the market rally, indicating a possible shift in sentiment.
  • The fluctuating movements in CRON following Trump's post highlight the unpredictable nature of cannabis stocks in response to political and regulatory developments.

28.07.2025 - CRON Stock was up 5.1%

  • Cronos stock saw a notable upswing today, hitting a three-year peak, subsequent to the disclosure of a strategic partnership with Trump Media Group. This partnership entailed a substantial financial investment in Cronos through a $6.4 billion CRO treasury move.
  • The collaboration with Trump Media Group, which involves the establishment of a CRO Strategy supported by a significant investment in CRO tokens, cash, warrants, and credit line, has sparked enthusiasm and confidence among investors regarding Cronos' future outlook.
  • This strategic initiative not only injects a considerable sum of money into Cronos but also aligns the company with a reputable partner in the media industry, potentially paving the way for new growth opportunities and market expansion.
  • The market's favorable response underscores Cronos' ability to capitalize on its position in the cannabis sector and explore innovative prospects in collaboration with strategic allies.

27.01.2025 - CRON Stock was up 8.3%

  • Despite missing revenue estimates, CRON experienced a strong bullish movement due to a 27% increase in Q4 sales, driven by higher cannabis flower and extract sales.
  • The improved profitability, with gross profit rising significantly, contributed to the positive market sentiment.
  • Investors seem optimistic about CRON's performance, overlooking the revenue miss and focusing on the growth in net revenue for both Q4 and the full year.
  • The upcoming earnings conference call may provide further insights into the company's strategies and financial outlook, potentially sustaining the bullish momentum.

27.01.2025 - CRON Stock was up 3.5%

  • CRON witnessed a notable increase in its stock price today.
  • The positive movement could be linked to Cronos Group unveiling impressive financial results for the fourth quarter and full year of 2024, showing significant growth in net revenue.
  • The upcoming earnings conference call scheduled for February 27, 2025, likely encouraged optimism among investors, fueling expectations for further positive developments and growth opportunities.
  • The company's robust financial performance and investors' trust in its future prospects were key factors driving today's upward momentum in the stock price.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.